tiprankstipranks
Lantern Pharma Discusses Q3 Financial Results Webinar
Company Announcements

Lantern Pharma Discusses Q3 Financial Results Webinar

Pick the best stocks and maximize your portfolio:

Lantern Pharma ( (LTRN) ) just unveiled an update.

On November 7, 2024, the Company hosted a conference call and live webinar to discuss its third-quarter financial results, utilizing a presentation to assist the discussions. This information is part of a Current Report but is not considered filed under the Securities Exchange Act of 1934, meaning it doesn’t carry certain legal liabilities.

For an in-depth examination of LTRN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyLantern Pharma doses first patient in LP-300 trial
TheFlyLantern Pharma granted fast track designation for LP-184
TheFlyLantern Pharma doses first patient in LP-300 trial expansion cohort
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App